organophosphonates has been researched along with glucagon-like peptide 1 in 1 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (glucagon-like peptide 1) | Trials (glucagon-like peptide 1) | Recent Studies (post-2010) (glucagon-like peptide 1) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 9,484 | 1,208 | 6,374 |
| Protein | Taxonomy | organophosphonates (IC50) | glucagon-like peptide 1 (IC50) |
|---|---|---|---|
| Glucagon-like peptide 1 receptor | Homo sapiens (human) | 0.0051 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, EB; Hwang, JI; Kim, DK; Kim, HY; Moon, MJ; Park, S; Seong, JY | 1 |
1 other study(ies) available for organophosphonates and glucagon-like peptide 1
| Article | Year |
|---|---|
Insulin contributes to fine-tuning of the pancreatic beta-cell response to glucagon-like peptide-1.
Topics: Animals; Cell Line; ErbB Receptors; Glucagon-Like Peptide 1; Glucose; Insulin; Insulin-Secreting Cells; Isoquinolines; Naphthalenes; Oncogene Protein v-akt; Organophosphonates; Phosphorylation; Quinazolines; Rats; Receptor Cross-Talk; Receptors, AMPA; Tetrazoles; Tyrphostins | 2011 |